180 Development and validation of a pharmaceutical care plan for patients with type 2 diabetes

Sunday, April 26, 2009
Dalal Al-Taweel, MPharm, MSc, MRPharmS , Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
Steve Hudson, Professor , Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0NR, United Kingdom
Abdelmoneim A. Hussein, BPharm, MPharm, PhD , Kuwait University, Kuwait City, Kuwait